Delivery Order SPE2DB20D3303-SPE2DB23FA1WP
Award Date 9/29/23
Potential Completion Date 10/2/23
Potential Value $9.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.47 firm-fixed-price contract is for the delivery of 180 units of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,911.42 and an ultimate completion date of June 26, 2025. The contract is for the delivery of 120 tablets of the medication Mesalamine DR 1.2 GM. This is an open competition contract, as it does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 180 800-milligram delayed-release mesalamine tablets. The $6,145.71 contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $2,098.63 and is for the delivery of 120 units of the pharmaceutical product Mesalamine 1.2 grams. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine DR 1.2 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has a firm fixed price of $6,083.81 and a completion date of July 3, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,497.63 firm fixed price contract is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release medication. The contract has an ultimate completion date of January 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.75 firm fixed-price contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of April 10, 2025 and is not associated with any set-aside requirements. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,284.56 fixed-price delivery order is for the supply of 180 capsules of 400 mg Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of March 19, 2025 and is not designated with any set-aside requirements, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,713,896 tablets of the medication Mesalamine DR 1.2 gram, with a ceiling value of $5,692.07. The contract is a firm fixed price delivery order with a period of performance extending to February 21, 2024. This award is part of a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,942,947 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $2,002.92 and a completion date of April 17, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating...